FDA Approves OXCARBAZEPINE — ANI Pharmaceuticals, Inc.

# FDA Approves ANI Pharmaceuticals' Generic Oxcarbazepine ANI Pharmaceuticals, Inc. received FDA approval for its generic oxcarbazepine oral formulation, expanding the competitive landscape in the anticonvulsant market and providing patients with a more affordable alternative to branded seizure medications. The approval of this generic entry is expected to drive down pricing in the oxcarbazepine market while strengthening ANI's position in the generic pharmaceutical sector.